Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies

Author： Grassadonia Antonino   Cioffi Pasquale   Simiele Felice   Iezzi Laura   Zilli Marinella   Natoli Clara  

Publisher： MDPI

E-ISSN： 2072-6694|5|3|919-942

ISSN： 2072-6694

Source： Cancers, Vol.5, Iss.3, 2013-07, pp. : 919-942

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies

By Ellis Leigh   Pili Roberto  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2441-2469

MDPI

Access to resources Recommend Favorite

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies

By Bishton Mark J.   Johnstone Ricky W.   Dickinson Michael   Harrison Simon   Prince H. Miles  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2674-2688

MDPI

Access to resources Recommend Favorite

Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors

By Rikiishi Hidemi  

Cancers, Vol. 2, Iss. 4, 2010-11 ,pp. : 2026-2043

MDPI

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors as Anticancer Drugs

By Eckschlager Tomas   Plch Johana   Stiborova Marie   Hrabeta Jan  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1414-1414

MDPI

Access to resources Recommend Favorite

Clinical Toxicities of Histone Deacetylase Inhibitors

By Subramanian Srividya   Bates Susan E.   Wright John J.   Espinoza-Delgado Igor   Piekarz Richard L.  

Pharmaceuticals, Vol. 3, Iss. 9, 2010-08 ,pp. : 2751-2767

MDPI

Access to resources Recommend Favorite